Journal of Comparative Effectiveness Research

Papers
(The median citation count of Journal of Comparative Effectiveness Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants86
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study78
Efficacy classification of modern therapies in multiple sclerosis58
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis44
The prevalence, characteristics and treatment of hemorrhoidal disease: results of an international web-based survey40
Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy38
Early mobilization in enhanced recovery after surgery pathways: current evidence and recent advancements36
Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance31
Evidence-based public policy making for medicines across countries: findings and implications for the future29
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients27
Clinical therapeutic efficacy of mesenchymal stem cells derived from adipose or bone marrow for knee osteoarthritis: a meta-analysis of randomized controlled trials26
Lenvatinib versus sorafenib for unresectable hepatocellular carcinoma: a cost–effectiveness analysis24
COVID-19 complications in males and females: recent developments20
The use of nonrandomized evidence to estimate treatment effects in health technology assessment18
Patient-related barriers to some virtual healthcare services among cancer patients in the USA: a population-based study18
Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-201918
Robot-assisted minimally invasive transforaminal lumbar interbody fusion versus open transforaminal lumbar interbody fusion: a retrospective matched-control analysis for clinical and quality-of-life o15
What is a meta-epidemiological study? Analysis of published literature indicated heterogeneous study designs and definitions15
Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus14
What works when: mapping patient and stakeholder engagement methods along the ten-step continuum framework14
The prevalence, disease characteristics and treatment of chronic venous disease: an international web-based survey14
Replication of randomized clinical trial results using real-world data: paving the way for effectiveness decisions14
Web-based decision aids to support breast cancer screening decisions: systematic review and meta-analysis14
Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study)13
Evaluating patients' satisfaction and preferences with a secondary prevention cardiovascular polypill: the Aurora Study13
Real-world evidence and nonrandomized data in health technology assessment: using existing methods to address unmeasured confounding?12
The problem of underdosing with direct-acting oral anticoagulants in elderly patients with nonvalvular atrial fibrillation12
How does risdiplam compare with other treatments for Types 1–3 spinal muscular atrophy: a systematic literature review and indirect treatment comparison12
Robotic-assisted total hip arthroplasty: an economic analysis12
Economic analysis of the use of video laryngoscopy versus direct laryngoscopy in the surgical setting12
Network meta-analysis of nivolumab plus ipilimumab in the second-line setting for advanced hepatocellular carcinoma12
A prospective, randomized, controlled, crossover study comparing three multilayered foam dressings for the management of chronic wounds12
Vaginal laser therapy for gynecologic conditions: re-examining the controversy and where do we go from here11
Unmeasured confounding in nonrandomized studies: quantitative bias analysis in health technology assessment11
Cost–effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke11
Cost–effectiveness of empagliflozin compared with liraglutide based on cardiovascular outcome trials in Type II diabetes11
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer10
Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data inROS1+ NSCLC10
Factors influencing breast cancer awareness: a cross-sectional study in China10
Digital technologies in cancer care: a review from the clinician's perspective10
An investigation to choose the proper therapy technique in the management of autism spectrum disorder10
Estimates of the value of life lost from COVID-19 in Ohio10
Impact of socioeconomic status on presentation, treatment and outcomes of patients with pancreatic cancer9
Impact of telehealth on health care resource utilization during the COVID-19 pandemic9
Matching-adjusted indirect comparison: entrectinib versus crizotinib in ROS1 fusion-positive non-small cell lung cancer9
Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA9
Advancing community-engaged research: increasing trustworthiness within community-academic partnerships9
Propensity score matching versus coarsened exact matching in observational comparative effectiveness research9
Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease9
Indirect treatment comparison of idecabtagene vicleucel versus conventional care in triple-class exposed multiple myeloma9
Potential policy reforms to strengthen the accelerated approval pathway8
Effectiveness of clinical Pilates and home exercises in sagittal cervical disorientation: randomized controlled study8
The cost–effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark8
Patient and caregiver experiences at a specialized primary care center for autistic adults8
Assessing direct costs of treating metastatic triple-negative breast cancer in the USA8
Real-world evidence on clinical outcomes in immune thrombocytopenia treated with thrombopoietin receptor agonists8
The next generation of rare disease drug policy: ensuring both innovation and affordability8
Venous stenting for patients with outflow obstruction and leg ulcers: cost–effectiveness and budget impact analyses7
CAR-T therapy and historical trends in effectiveness and cost–effectiveness of oncology treatments7
Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers7
Missing data methods for intensive care unit SOFA scores in electronic health records studies: results from a Monte Carlo simulation7
Identifying patient decisions and related information needs during decision making related to total knee arthroplasty7
Comparison of intravenous versus topical tranexamic acid in primary total hip arthroplasty: a systematic review and meta-analysis of ten randomized trials7
Safety and effectiveness of intranasal esketamine for treatment-resistant depression: a real-world retrospective study7
Healthcare use and costs among Medicare enrollees on pirfenidone versus nintedanib for idiopathic pulmonary fibrosis7
US cost–effectiveness of polatuzumab vedotin, bendamustine and rituximab in diffuse large B-cell lymphoma7
Efficacy of immunotherapy with PD-1 inhibitor in colorectal cancer: a meta-analysis7
Type I collagen matrix plus polyhexamethylene biguanide antimicrobial for the treatment of cutaneous wounds7
Assessing risk of bias judgments for blinding of outcome assessors in Cochrane reviews7
Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy7
Real-world treatment, clinical outcomes and healthcare resource utilization among persons with hemophilia A by age7
Golimumab improves patient-reported outcomes in daily practice of inflammatory rheumatic diseases in Germany6
Single-arm oncology trials and the nature of external controls arms6
Palbociclib versus abemaciclib in HR+/HER2- advanced breast cancer: an indirect comparison of patient-reported end points6
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis6
The effects of pregnancy on relapse rates, disability and peripartum outcomes in women with multiple sclerosis: a systematic review and meta-analysis6
Meta-analysis of immunogenicity and safety of human rabies vaccination under Zagreb and Essen regimens6
Real-world switch patterns and healthcare costs in biologic-naive psoriasis patients initiating apremilast or biologics6
Protocol for Digital Real-world Evidence trial for Adults with insomnia treated via Mobile (DREAM): an open-label trial of a prescription digital therapeutic for treating patients with chronic insomni6
Effect of clinical Pilates training on balance and postural control in patients with Parkinson’s disease: a randomized controlled trial6
Use of ibuprofen for the closure of patent ductus arteriosus in preterm infants: a systematic review of meta-analyses6
A systematic review of discounting in national health economic evaluation guidelines: healthcare value implications6
Analyzing the concept of spillover effects for expanded inclusion in health economics research6
Health technology assessment (HTA) in England, France and Germany: what do matched drug pairs tell us about recommendations by national HTA agencies?6
The terminology conflict on efficacy and effectiveness in healthcare6
Advantages of robotic arm-assisted total hip arthroplasty: a 90-day episode-of-care clinical utility and cost analysis6
Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case–control design6
Effects of 12-week Pilates training program on cardiac autonomic modulation: a randomized controlled clinical trial6
Implementation of the Connect for Health pediatric weight management program: study protocol and baseline characteristics5
The triple win – implementation science benefits patients, healthcare systems and industry alike5
TELEmedicine as an intervention for sepsis in emergency departments: a multicenter, comparative effectiveness study (TELEvISED Study)5
Intracardiac echocardiography use and outcomes after catheter ablation of ventricular tachycardia5
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 85
An observational cohort study of pelvic floor photobiomodulation for treatment of chronic pelvic pain5
Estimating the risk of thrombotic events in people with congenital hemophilia A using US claims data5
Cornerstones of ‘fair’ drug coverage: appropriate cost sharing and utilization management policies for pharmaceuticals5
No protocol and no liability: a call for COVID crisis guidelines that protect vulnerable populations5
Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancer5
Approaches for the identification of chronic kidney disease in CPRD–HES-linked studies5
Tisagenlecleucel versus historical standard therapies for pediatric relapsed/refractory acute lymphoblastic leukemia5
Six ways to foster community-engaged research during times of societal crises5
Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy5
Are eSports more than just sitting? A study comparing energy expenditure5
Do implantable loop recorders impact the survival of patients with recurrent unexplained syncope?5
The efficacy of 3D printing-assisted surgery in treating distal radius fractures: systematic review and meta-analysis5
A review of stakeholder recommendations for defining fit-for-purpose real-world evidence algorithms5
Respiratory and nonrespiratory COVID-19 complications in patients with obesity: recent developments5
Cost–effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain5
Factors affecting treatment selection and overall survival for first-line EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer5
Cost-per-remitter with esketamine nasal spray versus standard of care for treatment-resistant depression5
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment5
The cost–effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK setting5
Comparative efficacy of dabrafenib + trametinib versus treatment options for metastatic melanoma in first-line settings4
Safety and efficacy of GP40071 compared with originator insulin aspart (NovoRapid ® Penfill ® ) in Type 1 diabetes mellitus4
Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil: a cross-sectional study and the implications4
Comparative effectiveness of trastuzumab emtansine versus lapatinib plus chemotherapy for HER2+ metastatic breast cancer4
Engaging patients and stakeholders in preresearch: findings from the Pipeline to Proposal Awards Initiative4
The economic cost of racial disparities in perioperative care4
European cooperation in health technology assessment implementation: the perspective of Central and Eastern European countries4
Meta-analysis of visual pretreatment for the prevention of emergence delirium in children undergoing ophthalmic surgery4
Surfactant therapy for meconium aspiration syndrome in neonates: a systematic overview of systematic reviews and recent clinical trials4
Strategies to improve the availability of medicines in primary health care in Brazil: findings and implications4
Influence of pharmaceutical services organization on the availability of essential medicines in a public health system4
Dacomitinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: a cost–effectiveness analysis4
High-concentration nonavian high-molecular weight hyaluronan injections and time-to-total knee replacement surgery4
Optimizing electronic capture of patient-reported outcome measures in oncology clinical trials: lessons learned from a qualitative study4
Social determinants of health affect unplanned readmissions following acute myocardial infarction4
Cost–effectiveness analysis of empagliflozin compared with glimepiride in patients with Type 2 diabetes in China4
Indirect treatment comparison of olaparib and talazoparib in germline BRCA-mutated HER2-negative metastatic breast cancer4
The societal impact of a biologic treatment of ankylosing spondylitis: a case study based on secukinumab4
Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in colorectal cancer: a meta-analysis4
Sex-based differences in the outcomes of patients with lung carcinoids4
Gender, socioeconomic status and emergency department visits among cancer survivors in the USA: a population-based study4
Minimally invasive surgery for low-grade spondylolisthesis: percutaneous endoscopic or oblique lumbar interbody fusion4
Semaglutide treatment for obesity in teenagers: a plain language summary of the STEP TEENS research study4
Application of quantitative bias analysis for unmeasured confounding in cost–effectiveness modelling4
Is Medicaid expansion associated with increases in palliative treatments for metastatic cancer?4
Comparative effectiveness of glasdegib versus venetoclax combined with low-dose cytarabine in acute myeloid leukemia4
Nonindependence of patient data in the clinical practice research datalink: a case study in atrial fibrillation patients4
Real-world direct healthcare costs of treating recurrent high-grade serous ovarian cancer with cytotoxic chemotherapy4
Comparative effectiveness of weekly versus every-2-weeks cetuximab in metastatic colorectal cancer in a US-insured population4
Recommendations from Cochrane reviews for improving future trials on anesthesia and pain: a meta-research study3
Effects of two different stretching techniques on proprioception and hamstring flexibility: a pilot study3
Willingness to pay for a hypothetical malaria vaccine in Brazil: a cross-sectional study and the implications3
Opicapone as an add-on to levodopa for reducing end-of-dose motor fluctuations in Parkinson’s disease: a systematic review and meta-analysis3
Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-world study3
Adding pertuzumab to adjuvant therapy for high-risk HER2-positive early breast cancer in APHINITY: a GRADE analysis3
Reliability of quantitative ultrasound measurement of flexor digitorum superficialis and profundus muscles in stroke3
Learning from the past to advance tomorrow’s real-world evidence: what demonstration projects have to teach us3
Life after COVID-19: R WE going to help?3
The impact of lower limb chronic venous disease on quality of life: patient and physician perspectives3
US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior3
Knowledge, awareness and perceptions of diabetes mellitus among the Saudi population3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 123
A comparative cost analysis between two quick diagnosis units of different levels of complexity3
Causal inference and adjustment for reference-arm risk in indirect treatment comparison meta-analysis3
Prednisone and deflazacort in Duchenne muscular dystrophy: a patient perspective and plain language summary publication of the Cincinnati study3
Continuous vital sign monitoring in patients after elective abdominal surgery: a retrospective study on clinical outcomes and costs3
Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema3
R WE ready for reimbursement? A round up of developments in RWE relating to health technology assessment: part 23
Shifting demographics and comorbidity burden in adult Chinese urban patients with chronic hepatitis B, 2013 and 20163
A comparative network meta-analysis of standard of care treatments in treatment-naïve chronic hepatitis B patients3
The impact of implementation of a hysterectomy enhanced recovery pathway on anesthetic medication costs3
Access to medicines in the Brazilian Unified Health System’s primary health care: assessment of a public policy3
Economic burden of lives lost due to COVID-19 in New York State3
Assessing potential cures: are there distinctive elements of value beyond health gain?3
The prognostic impact of renal function decline during hospitalization for myocardial infarction3
Comparative effectiveness research in COVID-19 using real-world data: methodological considerations3
Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis3
Predicting optimal treatment regimens for patients with HR+/HER2- breast cancer using machine learning based on electronic health records3
Real-world healthcare resource utilization and costs of weekly versus every-2-week cetuximab in metastatic colorectal cancer3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 93
Why, whether and how to use high-flow nasal therapy in acute exacerbations of chronic obstructive pulmonary disease3
Adoption of video laryngoscopy by a major academic anesthesia department3
SPECT/CT versus planar imaging to determine treatment strategy for non-small-cell lung cancer: a cost–effectiveness analysis3
Reasons and factors associated with inconclusiveness of systematic reviews about interventions for neuropathic pain3
The economic cost of racial disparities in chronic pain3
Steroid switching in dystrophinopathy treatment: a US chart review of patient characteristics and clinical outcomes3
Cost–effectiveness of second-line nivolumab for platinum-treated advanced non-small-cell lung cancer3
Impact of clinical research coordinators on research output in orthopedic surgery3
Comparative effectiveness of larotrectinib versus entrectinib for the treatment of metastatic NTRK gene fusion cancers3
The health-related quality of life of patients with a benign gynecological condition: a 2-year follow-up3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 103
Patient and stakeholder engagement learnings: PREP-IT as a case study3
Healthcare utilization among children with early autism diagnoses, children with other developmental delays and a comparison group3
Medication review with follow-up for cardiovascular outcomes: a trial based cost–utility analysis2
Economic burden of drug overdose deaths before and during the COVID-19 pandemic in the USA2
Usability evaluation of sufentanil sublingual tablet analgesia in patients following Enhanced Recovery After Surgery2
Structural hemodynamic valve deterioration durability of RESILIA-tissue versus contemporary aortic bioprostheses2
Antibacterial data synthesis challenges: a systematic review of treatments for complicated Gram-negative urinary tract infections2
Impact of osteosynthesis in fracture care: a cost comparison study2
Economic burden of maternal mortality in the USA, 2018–20202
Economic burden of readmission due to postoperative cerebrospinal fluid leak in Chinese patients2
Cost–utility analysis of single nucleotide polymorphism panel-based machine learning algorithm to predict risk of opioid use disorder2
DAPA-RWE: a retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain2
Bridging the gap between oncology clinical trials and real-world data: evidence on replicability of efficacy results using German claims data2
Institute for Clinical and Economic Review – Peterson Health Technology Institute value assessment framework for digital health technologies2
Comparison of Enterprise stent 2 with 1 in assisting coiling of ruptured aneurysms: a real-world study2
A proposed framework for patient engagement throughout the broader research enterprise2
Economics of implementing an early deterioration detection solution for general care patients at a US hospital2
Health benefits and economic advantages associated with increased utilization of a smoking cessation program2
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 42
Breast-conserving surgery versus mastectomy for older women with triple-negative breast cancer: population-based study2
Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making2
Impact of clinical pathways on treatment patterns and outcomes for patients with non-small-cell lung cancer: real-world evidence from a community oncology practice2
Efficacy and safety of GP40021 insulin lispro biphasic compared with Humalog Mix 25 in Type 2 diabetes mellitus patients2
Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink2
Cost-minimization analysis of negative pressure wound therapy technologies for the treatment of moderate-to-severe foot infections2
Cost-minimization analysis of teledermatology versus conventional care in the Brazilian National Health System2
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 112
The effects of Pilates on pain, functionality, quality of life, flexibility and endurance in lumbar disc herniation2
For what it's worth: the complex area of medicine value assessment2
Clinical outcomes of powered and manual staplers in video-assisted thoracic surgery lobectomy for lung cancer2
True cost of surgical aortic valve replacement and implications for price setting and diagnosis-related groups: evidence from a tertiary hospital in Eastern China2
Adjusting for treatment crossover in the MAVORIC trial: survival in advanced mycosis fungoides and Sézary syndrome2
Autograft versus allograft tenodesis for chronic ankle instability: a single-center retrospective comparative study2
Data limitations of administrative databases in examining healthcare disparities in anesthesiology2
Discharges against medical advice and 30-day healthcare costs: an analysis of commercially insured adults2
Evaluation of patient/caregiver and healthcare provider knowledge, attitudes and behavior for safety and use of pexidartinib2
MASTRO I: Meta-Analysis and Systematic Review of thrombectomy stent retriever outcomes: comparing functional, safety and recanalization outcomes between EmboTrap, Solitaire and Trevo in acute ischemic2
Healthcare utilization in clinically significant tricuspid regurgitation patients with and without heart failure2
Cost–effectiveness of ensartinib for patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer in China2
The use of real-world effectiveness measurements in clinical settings at Helsinki University Hospital: a systematic literature review2
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 72
Switch rates and total cost associated with apremilast and biologics in biologic-naive patients with psoriatic arthritis2
Comparison of the effects of progressive supervised and home program exercise therapy in mild–moderatehallux valgus2
Engaging veterans in the research process: a practical guide2
Impact of comparative effectiveness research on Medicare coverage of direct oral anticoagulants2
Navigating adalimumab biosimilars: an expert opinion2
An economic and health outcome evaluation of telehealth in rural sepsis care: a comparative effectiveness study2
Patients’ perceptions with dabigatran in patients with atrial fibrillation previously treated with vitamin K antagonists2
Characteristics of patients with chronic kidney disease and Type 2 diabetes initiating finerenone in the USA: a multi-database, cross-sectional study2
Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration2
Outcome domains and measures for pain in psoriasis used in registered trials: analysis of studies on ClinicalTrials.gov2
Identifying the unmet needs of individuals with Type 2 diabetes: an international web-based survey2
Economic burden of rivaroxaban and warfarin among nonvalvular atrial fibrillation patients with obesity and polypharmacy2
Comparison of noninvasive prenatal screening for defined pathogenic microdeletion/microduplication syndromes and nonsyndromic copy number variations: a large multicenter study2
Clinical manifestations and healthcare utilization before diagnosis of transthyretin amyloidosis2
Factors impacting self-management ability in patients with chronic diseases in the United Arab Emirates, 20192
Real-world economic and clinical outcomes associated with current hemostatic matrix use in spinal surgery2
Understanding characteristics of patients newly initiating ixekizumab: findings from the Corrona Psoriasis Registry2
Impact of chronic obstructive pulmonary disease on mortality in community acquired pneumonia: a meta-analysis2
Review and estimation of disutility for joint health states of severe and nonsevere hypoglycemic events in diabetes2
Economic impact of multigene panel testing for hereditary breast and ovarian cancer2
Disease burden of schizophrenia patients visiting a Chinese regional mental health centre2
Patterns of emergency department visits preceding colorectal cancer diagnosis: a population-based study2
Cost–effectiveness of empagliflozin versus weekly semaglutide as add-on therapy for Type 2 diabetes2
Burden of tyrosine kinase inhibitor failure in Chinese chronic myeloid leukemia patients: a systematic literature review2
Cost–effectiveness of pembrolizumab for second-line treatment of esophageal squamous cell carcinoma patients with a combined positive score of 10 or more2
Channeling effects in the prescription of new therapies: the case of emicizumab for hemophilia A2
0.048874855041504